baber/WOPTO huggingface dataset:
Patent EP-1385901-A2 (EP)
Inventor: HUGHES SHANNON K
IPC: C08J9/26
Filed: 2002-01-23
Abstract: Microporous materials and articles are disclosed. The microporous materials contain a crystallizable propylene-containing polymer, a beta-nucleating agent, and a diluent that is miscible with the polymer at a temperature above the melting temperature of the polymer and that phase separates from the polymer at a temperature below the polymer crystallization temperature. The invention is also directed to methods of forming the microporous material using thermal induced phase separation and subsequent processing.</PTEXT>
Patent EP-1412903-A2 (EP)
Inventor: KETTLER EDWARD W III
IPC: G06Q10/06
Filed: 2002-07-19
Abstract: l'invention concerne, dans une réalisation, un procédé destiné à réaliser la cohérence de données dans un système de planification de ressources d'entreprise. Un premier ensemble de données de structure est reçu et envoyé à deux ou à plusieurs systèmes de planification de ressources d'entreprise. Les systèmes de planification de ressources sont associés à une seule affaire ou à un groupe d'entreprises affilées et chacun maintient ses propres données de structure. L'envoi du premier ensemble de données de structure provoque dans chaque système de planification de ressources d'entreprise la création ou le changement de leurs propres données de structure.
Patent EP-1490261-A2 (EP)
Inventor: NIELSEN PETER BRINCH
IPC: B63C9/02
Filed: 2002-10-09
Abstract: A mooring system ( 28 ) of a floatable unit ( 20 ), such as life raft or platform, the floatable unit ( 20 ) having a first side ( 21 ) facing a vessel side ( 22 ) and a second side ( 23 ) facing away from the vessel side ( 22 ). The mooring system ( 28 ) comprises at least two back springs ( 2 ) which are in connection with the first side ( 21 ) of the floatable unit ( 20 ), and at least one strap ( 1 ) which is in connection with the second side ( 23 ) of the floatable unit ( 20 ), the back springs ( 2 ) and the strap ( 1 ) being connected to the vessel ( 30 ). The back springs ( 2 ) are adapted to control the floatable unit ( 20 ) in a longitudinal direction in relation to the vessel ( 30 ), and the strap ( 1 ) is adapted to control the floatable unit ( 20 ) in a transverse direction in relation to the vessel ( 30 ). The floatable unit is held in secure and fixed position alongside the vessel side, thereby enabling people evacuating from the vessel to enter the floatable unit without any high risk of injury or damage.
Patent EP-1455757-A2 (EP)
Inventor: FERGIONE MICHAEL B
IPC: A61K9/26
Filed: 2002-12-09
Abstract: L'invention concerne un procédé permettant de former des granules d'azithromycine non-dihydrate et consistant à mélanger des particules d'azithromycine non-dihydrate avec une quantité de granulation d'un liquide de granulation et éventuellement avec des particules d'un ou de plusieurs excipients, de manière à former des granules humides renfermant une azithromycine non-dihydrate et le liquide de granulation. Les granules sont ensuite séchées aux fins d'élimination du liquide de granulation. L'invention concerne également une composition pharmaceutique renfermant des granules d'une azithromycine non-dihydrate et au moins un excipient acceptable sur le plan pharmaceutique ; ainsi que des formulations pharmaceutiques comprenant des granules d'azithromycine non-dihydrate. L'invention concerne enfin des granules d'azithromycine non-dihydrate comprenant au moins 98 % d'azithromycine non-dihydrate et entre environ 2 % et 0 %, en poids total, d'au moins un excipient acceptable sur le plan pharmaceutique.
Patent EP-1468287-A2 (EP)
Inventor: CHEN JIAN
IPC: C12Q1/48
Filed: 2002-12-30
Abstract: Methods and systems of applying mass spectrometry to the analysis of peptides and amino acids, especially in the proteome setting. More particularly, the invention relates to a mass spectrometry-based method for detection of amino acid modifications such as phosphorylation.
Patent EP-1409240-A2 (EP)
Inventor: TREADWAY JOSEPH A
IPC: H01L33/00
Filed: 2002-07-17
Abstract: Methods for synthesizing luminescent nanoparticles and nanoparticles prepared by such methods are provided. The nanoparticles are prepared by a method in which an additive is included in the reaction mixture. The additive may be a Group 2 element, a Group 12 element, a Group 13 element, a Group 14 element, a Group 15 element, or a Group 16 element. In additions, a luminescent nanoparticle is provided that comprises a semiconductive core surrounded by an inorganic shell, an interfacial region and an additive present in the interfacial region or both the interfacial region and the shell.
Patent EP-1352986-A2 (EP)
Inventor: TAKAHASHI KOYATA
IPC: C23C4/10
Filed: 2003-04-03
Abstract: Parts, especially those formed of quartz glass, for film-forming devices,
plasma-treating devices and the like have a problem of inner pollution of the devices
with particles given by dropping of deposit films from the parts, a problem of
hermetical sealing reduction due to bonding failure of the parts to other parts, and a
problem of energy efficiency reduction due to the heat insulation failure in the parts.
Parts having a thermal sprayed quartz glass film formed on a substrate have an
increased ability to hold a deposit thereon, and have an increased ability to
hermetically bond to other parts. The parts having a thermal sprayed black quartz
glass film have an increased ability of heat insulation property. Even when washed
with acid, the abilities of the parts do not lower. The parts can be used for a long
period of time and their life is long.
Patent EP-1406197-A2 (EP)
Inventor: MOTOKI WATARU
IPC: G16H30/20
Filed: 2003-08-01
Abstract: A display control unit displays the photography management screen that manages medical image photography operation of the readers (2,3,4) in the same screen, based on the photography reservation information on the display unit. A controller (1) controls medical image photography operation of the readers indicated in photography management screen, through network. Independent claims are also included for the following: (1) medical image control system; and (2) medical image control program.
Patent EP-1366787-A2 (EP)
Inventor: DEWA SHOJI
IPC: A63F9/00
Filed: 2001-02-14
Abstract: In a die which has a regular polyhedron form and which can be opened
into a continuous polygonal form on a plane, boundary areas (Rb) between
planes (11 through 16) on the inner side of the regular polyhedron have
inclination angles determined according to the regular polyhedron. In addition,
engaging portions (21 a, 21 b, 24a, 24b, 25a, 25b, 26a, 26b) not exceeding the
respective boundary areas (Rb) are placed on the boundary areas (Rb) of
predetermined planes (11 through 16). Such a die is formed by injecting
plastic resin within a mold (31, 32) according to the form of the opened die.
This realizes a three-dimensional die capable of being opened onto a two-dimensional
plane, which has only been fictionally conceived, and further
provides a manufacturing method thereof.
Patent EP-1420309-A2 (EP)
Inventor: FISCHBACH GUNTHER
IPC: B29C45/76
Filed: 2003-09-26
Abstract: The control for plastics machines has a central CPU (10) with a real time operating system, linked to actuators and/or sensors (S1,S2-Sn) through a bus (16). At least one actuator and/or sensor is structured for rapidly changing values with a high resolution. An initial processing unit (20) has at least one application specific integrated circuit (ASIC) or a freely programmable gate array (FPGA), with a link to at least one actuator and/or sensor. An input/output (I/O) unit (22) is connected directly to the bus link.
Patent EP-1416114-A2 (EP)
Inventor: BEU REINER
IPC: E06B1/70
Filed: 2003-10-29
Abstract: The method involves: (1) providing a simple metal profile having a rectangular base plate (4) with an outer web (1) and two inner webs (2,3), the part of base plate protruding beyond the innermost web defining the vertical section of the finished end cap;  (2) cutting profile to length;  (3) removing a first part (5) of the base plate along the outer web and removing a second part (6) along the innermost web so that the base plate becomes essentially L-shaped with an elongated free outer web section; and  (4) bending the free outer web section to be secured to a front edge (8) defined by one of the arms of the L. The end cap has an essentially horizontal section connected to a front section extending essentially in a vertically downwards direction. Two webs extending along a lower edge of the horizontal section are used to locate the end of the window sill and optionally a seal, leaving sufficient space for the angled end of the sill.
Patent EP-1335367-A2 (EP)
Inventor: SUGIYAMA KOICHI
IPC: H04N5/765
Filed: 1995-12-20
Abstract: Copying, dubbing or reproducing copyrighted digital data can
be inhibited or restricted to properly protect a copyright. AV
data recorded on a pre-recorded tape is output from a reproducing
unit of a first digital VCR with protective information
indicating whether the copy of the AV data is inhibited or not.
The protective information is input with the A/V data to a second
digital VCR. Copy permission information of a blank tape loaded
in the second digital VCR is discriminated and the second digital
VCR records the AV data supplied from the first digital VCR based
on the protective information and the copy permission
information.
Patent EP-1416182-A2 (EP)
Inventor: TERAKAWA TOMOMITSU
IPC: B60W10/04
Filed: 2003-10-30
Abstract: A clutch control device includes estimating means for estimating the temperature of the
clutch disc, and correcting means for correcting the control amount imposed by the
actuator based upon the estimated temperature of the clutch disc. The correcting means
preferably corrects the control amount imposed by the actuator based upon the variation
of a friction coefficient at the estimated temperature of the clutch disc.
Patent EP-1344727-A2 (EP)
Inventor: TSOUKALAS GEORGE
IPC: G01M3/26
Filed: 2003-03-07
Abstract: A conveyor assembly 18 that detects bags that leak. The assembly 18 includes a
first conveyor 24 that operates in unison with a second conveyor 29. The conveyors 24
and 29 confine the bags in chambers, with the bags being engaged by pressure assemblies
50 so that the bags that leak are reduced in volume. The bags are engaged at a
downstream position and at an upstream position by detection devices 44 that provide a
signal indicative of the volume of each bag. These signals are compared to thereby
identify bags that leak.
Patent EP-1471910-A2 (EP)
Inventor: BAKTHAVATCHALAM RAJAGOPAL
IPC: A61K31/64
Filed: 2003-01-17
Abstract: L'invention concerne des analogues de quinazoline-4-ylamine substitués. Ces composés sont des ligands qui peuvent servir à moduler une activité de récepteur spécifique in vivo ou in vitro, et sont particulièrement utiles dans le traitement d'états associés à l'activation de récepteur pathologique chez l'être humain, les animaux domestiques et les animaux d'élevage. L'invention concerne également des compositions pharmaceutiques et des procédés d'utilisation de celles-ci destinés à traiter de tels troubles, ainsi que des procédés d'utilisation desdits ligands à des fins d'études de localisation de récepteur.
Patent EP-1501407-A2 (EP)
Inventor: KARAZIVAN NAIM
IPC: A61B6/14
Filed: 2003-05-08
Abstract: L'invention concerne un système de détection de caries dentaires sur une structure dentaire (T) comprenant un conducteur électromagnétique permettant de diriger au moins un rayonnement initial (Ir) sur une structure dentaire à évaluer, un collecteur électromagnétique permettant de recueillir au moins un rayonnement électromagnétique (Rr) qui a été au moins réfléchi par la dent (T) et transmis à travers cette dernière suite au rayonnement initial (Ir). Le collecteur est conçu pour transmettre le rayonnement électromagnétique obtenu (Rr) à un dispositif de détection (D). Ce dispositif de détection est conçu pour comparer au moins une intensité d'au moins un rayonnement obtenu (Rr) avec au moins une valeur prédéterminée qui correspond à une présence ou à une absence de caries dentaires. Ce système permet de diagnostiquer la présence ou l'absence de caries dentaires sur la structure dentaire.
Patent EP-1521740-A2 (EP)
Inventor: DEL SOLDATO PIERO
IPC: A61P1/04
Filed: 2003-03-19
Abstract: L'invention concerne des dérivés du probucol et des compositions pharmaceutiques contenant ces derniers, destinés à être utilisés pour le traitement ou la prophylaxie de maladies.
Patent EP-1525484-A2 (EP)
Inventor: NELSON LOREN D
IPC: G01S17/875
Filed: 2003-08-01
Abstract: Systems and methods for sensing air outside a moving aircraft are presented. In one embodiment, a system includes a laser for generating laser energy. The system also includes one or more transceivers for projecting the laser energy as laser radiation to the air. Subsequently, each transceiver receives laser energy as it is backscattered from the air. A computer processes signals from the transceivers to distinguish molecular scattered laser radiation from aerosol scattered laser radiation and determines one or more air parameters based on the scattered laser radiation. Such air parameters may include air speed, air pressure, air temperature and aircraft orientation angle, such as yaw, angle of attack and sideslip.
Patent EP-1537236-A2 (EP)
Title: Improved methods for the synthesis of nucleic acids
Inventor: KRUPP GUIDO
IPC: C12Q1/68
Filed: 2003-09-02
Abstract: The invention relates to a method for the synthesis of nucleic acids, wherein a polymerase, a nucleic acid which can act as a matrix for the polymerase, NTPs and Mn<2+> are incubated in certain conditions which enable the synthesis of a nucleic acid strand. Said method is characterised in that the conditions have a mol ratio of Mn<2+>/NTP which is not greater than 0.7.
Patent EP-1547163-A2 (EP)
Inventor: BOGNER GEORG
IPC: H01L33/48
Filed: 2003-09-29
Abstract: L'invention concerne un composant optoélectronique (1) qui comprend un ensemble semi-conducteur (4) émettant ou recevant un rayonnement électromagnétique et placé sur un support (22) relié thermoconducteur à un dissipateur thermique (12). Le composant optoélectronique selon l'invention comprend également des connexions électriques externes (9) reliées à l'ensemble semi-conducteur (4) et placées de manière électriquement isolée sur le dissipateur thermique (12) à distance du support (22). On obtient ainsi un composant optimisé en matière d'évacuation de la chaleur dissipée et d'émission lumineuse, ainsi que de mise en contact électrique et de densité des composants dans des modules.
Patent EP-1539522-A2 (EP)
Title: Commande de mouvement d'un transporteur
Inventor: KAMEN DEAN L
IPC: B60K31/00
Filed: 2003-07-11
Abstract: L'invention concerne un transporteur destiné à transporter un objet sur une surface pouvant être irrégulière. Le transporteur comprend une plateforme de support destinée à supporter une charge, la plateforme de support chargée définissant des plans longitudinaux et latéraux, et se caractérisant par une répartition de charge. Une pluralité d'éléments de contact au sol sont couplés à la plateforme de support de manière que le transporteur soit statiquement stable par rapport à un basculement dans le plan. Au moins un de la pluralité d'éléments de contact au sol est entraîné par un dispositif d'entraînement motorisé. Un module de détection génère un signal indicateur de la répartition de charge. Une unité de commande commande le dispositif d'entraînement motorisé, en fonction au moins de la répartition de charge.
Patent EP-1534320-A2 (EP)
Inventor: PAYS ETIENNE
IPC: G01N33/92
Filed: 2003-08-04
Abstract: The present invention is related to a composition comprising apolipoprotein L-l, the use of apolipoprotein L-l or a derivated polypeptide for the diagnostic, the treatment and/or the prevention of diseases induced in mammals by Trypanosoma. Another aspect is related to a transgenic non-human mammal comprising a polynucleotide expressing the apolipoprotein L-l or a derivated polypeptide and which is tolerant or resistant to the Trypanosoma infection.
Patent EP-1574100-A2 (EP)
Inventor: BEALE MARTIN
IPC: H04Q7/38
Filed: 2003-12-09
Abstract: In a CDMA system (100), two chip rates in a TDD cell are supported by: transmitting signals in the system in a frame (400) having a plurality of timeslots; operating at least a first one (0-8) of the plurality of timeslots in the frame at a lower chip rate; and operating at least a second one (9-14) of the plurality of timeslots in the frame at a higher chip rate. This provides the following advantages: provides backwards compatibility of a network including higher chip rate functionality with existing lower chip rate user equipment; allows greater network capacity during the transition phase from a low chip rate network to a high chip rate network; and allows a network operator with a high chip rate network to provide service to roaming users from low chip rate networks.
Patent EP-1565185-A2 (EP)
Inventor: YOUDIM MOUSSA B H
IPC: C07D295/205
Filed: 2003-11-07
Abstract: Cette invention concerne des chélateurs du fer dotés de propriétés neuroprotectrices et d'une bonne capacité au transport qui sont utiles dans la thérapie par chélation du fer pour le traitement de pathologies, troubles ou états associés à une surcharge en fer et à un stress oxydatif tels que : maladie ou trouble neurodégénératif ou cérébrovasculaire, maladie néoplasique, hémochromatose, thalassémie, maladie cardiovasculaire, diabète, troubles inflammatoires, cardiotoxicité des anthracyclines, infection virale, infection causée par des protozoaires, infection causée par des levures, ralentissement du vieillissement et prévention et/ou traitement du vieillissement de la peau et protection de la peau contre le rayonnement solaire et/ou le rayonnement ultraviolet. La fonction de chelation du fer est assurée par une 8-hydroquinoline, un hydropyridinone et une fraction hydroxamate, la fonction neuroprotectrice du composé par un peptide neuroprotecteur, et la fonction antiapoptotique et neuroprotective combinée par un groupe propargyle.
Patent EP-1563426-A2 (EP)
Inventor: BAM AJAY R
IPC: G06Q20/20
Filed: 2003-10-22
Abstract: L'invention concerne un système et un procédé de coordination d'une transaction consistant à entrer des informations relatives à la transaction au niveau d'un point de vente, les informations entrées étant indépendantes de l'identification d'un destinataire de la transaction. Indépendamment de l'entrée des informations, une connexion de communication est établie entre un dispositif uniquement associé au destinataire et un emplacement éloigné du point de vente. L'emplacement du point de vente est identifié au moyen de la communication de connexion établie et l'emplacement à distance coordonne l'emplacement du point de vente identifié avec les informations entrées en vue d'autoriser la transaction au niveau du point de vente. Dans un mode de réalisation, n'importe quelles autorisations secondaires, tels des engagements de fidélité, sont identifiées et n'importe quelles réductions sont faites aux informations entrées au niveau du point de vente. Dans un mode de réalisation, l'emplacement à distance permet le paiement du montant de la transaction par des tiers.
Patent EP-1546408-A2 (EP)
Inventor: GEPPERT MARTIN
IPC: C12Q1/68
Filed: 2003-09-05
Abstract: L'invention se rapporte à des procédés et à des compositions concernant l'ARN inhibiteur.
Patent EP-1569942-A2 (EP)
Inventor: ANDERSON DAVID R
IPC: C07D491/14
Filed: 2003-12-09
Abstract: Aminocyanopyridine compounds are described which are capable of inhibiting mitogen activated protein kinase-activated protein kinase-2. Pharmaceutical compositions and kits are also described, which include an anminocyanopyridine MK-2 inhibiting compound.
Patent EP-1578657-A2 (EP)
Inventor: REIMAN JAMES
IPC: B62D35/00
Filed: 2003-12-19
Abstract: A structure having a first semi-rigid surface with a first curved edge, the first semi-rigid surface adapted to be rotatably secured to a reference to permit the first semi-rigid surface to assume a first position and a second position, and a first joint structure spanning the first semi-rigid surface to permit the first semi-rigid surface to be folded when in the first position and unfolded when in the second position. The structure includes a second semi-rigid surface having a second curved edge, the second semi-rigid surface adapted to be rotatably secured to the reference to permit the second semi-rigid surface to assume a first position and a second position. The first and second semi-rigid surfaces are joined together at their first and second curved edges by a second joint structure adapted to permit the first and second semi-rigid surfaces to fold approximately together when the first and second semi-rigid surfaces are in their first positions.
Patent EP-1455023-A2 (EP)
Inventor: SCHMIDT MANFRED
IPC: E03B9/14
Filed: 2004-02-23
Abstract: The hydrant, especially below floor level, has a mantle pipe (10) with an attached valve housing which is fitted to the pipes of the mains network. The housing contains a main valve body (43) with a valve seat, and a spindle (41) through the housing cap (11) and through an inner cladding (42). A water removal system (30) has a bush (45) between the valve housing and/or the mantle pipe on one side, and the main valve body on the other side, which sets the main valve seat. At least one recess between the bush and the valve housing and/or mantle pipe forms at least one distribution chamber. At least one drilling carries the flow medium at the hydrant from the mantle pipe and over the main valve body to the distribution chamber, when the main valve is closed, and gives an uninterrupted flow when the valve is open. At least one water removal drilling (31) gives a flow through a drilling at the valve housing and/or a drilling through the mantle pipe to the outside of the hydrant. The metal bush of the main valve and/or the non-return valve is coated with rubber or plastics.
Patent EP-1437359-A2 (EP)
Inventor: KOBREHEL GABRIJELA
IPC: A61K31/7052
Filed: 1998-10-13
Abstract: The invention relates to
compounds of general formula
(I) characterized in that R 1 
individually stands for hydroxyl,
L-cladinosyl group of formula
(II) wherein R 2  individually
stands for hydrogen or a
silyl group; R 3  individually
stands for hydrogen or together
with R 6  stands for an ether
group; R 4  individually stands
for hydrogen, (C 1 -C 4 )acyl
group or -COO-(CH 2 ) n -Ar
group, wherein n is 1-7 and
Ar individually stands for
unsubstituted or substituted
aryl group with up to 18
carbon atoms; R 5  individually
stands for hydrogen, methyl
group or -COO-(CH 2 ) n -Ar
group, wherein n is 1-7 and
Ar individually stands for
unsubstituted or substituted aryl
group with up to 18 carbon
atoms; R 6  individually stands
for a hydroxyl group or together
with R 3  stands for an ether
group; R 7  individually stands
for hydrogen, (C 1 -C 12 )alkyl
group, silyl group or together with R g  and C-11/C-12 carbon atoms stands for a cyclic carbonate, R 8  individually stands for hydrogen,
(C 1 -C 12 )alkyl group, silyl group or together with R 7  and C-11/C-12 carbon atoms stands for a cyclic carbonate; and its pharmaceutically
acceptable additions salts with inorganic or organic acids, to a process for the preparation thereof and to the use thereof as antibiotics or
as intermediates for the synthesis of other macrolide antibiotics.